gip glp 1 agonist Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic GIP (Gastric Inhibitory Polypeptide) Assay

Description

For the first time ever, Medicare will cover GLP-1 medications specifically for weight loss, not just for diabetes or other conditions

thyroid C-cell tumor boxed warning

However, as the disease progresses, symptoms such as fatigue, abdominal discomfort, and unexplained weight loss may arise

We have already made the products for testing but cannot launch until patent expiration," GV Prasad, co-chairman and managing director, Dr Reddy's said.The company is strategically targeting markets where patents expire earliest, with India's launch timeline slightly later than Canada and Brazil, he indicated at the Nasscom GCC Summit here.The Hyderabad-based pharma major is looking at a portfolio of around 15 GLP-1 drugs that are used to treat diabetes and obesity, which it plans to roll out at various points in time based on patent expiry in different markets globally.He also highlighted the need for both innovator companies and generic manufacturers in the pharmaceutical industry